The intricate mechanisms underlying pathophysiology and progression of diabetes involve a complex interplay of genetic, metabolic, and immune factors. Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency, whereas type 2 diabetes is primarily driven by insulin resistance and progressive beta-cell dysfunction. Chronic hyperglycemia induces oxidative stress and inflammation, accelerating vascular and neural complications. Key signaling pathways, such as those involving insulin receptor substrates and glucose transporters, play crucial roles in disease development. Recent studies highlight the impact of gut microbiota, mitochondrial dysfunction, and lipid metabolism on diabetes progression. Understanding these molecular and cellular alterations is vital for developing targeted therapies aimed at preserving beta-cell function, enhancing insulin sensitivity, and preventing long-term complications.










Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou, Southern Medical University
Title : Diabetes pathogenesis and prevention
Madhu S Malo, Stapgen LLC
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar, Karnataka Institute of Endocrinology and Research
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal, New Era Consultancy Services
Title : Using a multi-disciplinary clinic model to prevent diabetic foot ulcer recurrence
Kaishi Yang, Albert Einstein College of Medicine
Title : Shaping the future of diabetes care: New advancements in treatment, digital health and personalized patient care
Rupesh K Gautam, Amity Institute of Pharmacy